Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goodman

Showing results (611-620 of 1,119) with videos related to

Pageof 112
Sort By:
CJC Open|June 27, 2023
Trends in major adverse cardiac events and healthcare utilization during the COVID-19 pandemic in Alberta, CanadaErin S Mackinnon, Todd Anderson, Paulo Raggi, et al.
American Journal of Nephrology|August 14, 2003
The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patientsGlenn M Chertow, Paolo Raggi, James T McCarthy, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2020
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trialsOlivia R Ghosh-Swaby, Shaun G Goodman, Lawrence A Leiter, et al.
American Heart Journal|November 24, 2007
Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcomeAndrew T Yan, Raymond T Yan, Mary Tan, et al.
The American Journal of Cardiology|October 30, 2010
Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatientsVineet Bhan, Raymond T Yan, Lawrence A Leiter, et al.
Circulation. Cardiovascular Interventions|November 6, 2024
Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS TrialAlexander C Fanaroff, Daniel M Wojdyla, Christopher B Granger, et al.
Journal of Invertebrate Pathology|July 18, 2017
Specificity and putative mode of action of a mosquito larvicidal toxin from the bacterium Xenorhabdus innexiIl-Hwan Kim, Jerald Ensign, Do-Young Kim, et al.
The Canadian Journal of Cardiology|November 19, 2013
Characteristics and evidence-based management of stable coronary artery disease patients in Canada compared with the rest of the world: insights from the CLARIFY registrySumeet Gandhi, Paul Dorian, Nicola Greenlaw, et al.
Kidney International|April 5, 2003
Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysisIsidro B Salusky, William G Goodman, Beatriz D Kuizon, et al.
CJC Open|September 30, 2020
Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary SyndromeDavid H Fitchett, Lawrence A Leiter, Peter Lin, et al.
Pageof 112

Showing results (611-620 of 1,119) with videos related to

Sort By:
Pageof 112
CJC Open|June 27, 2023
Trends in major adverse cardiac events and healthcare utilization during the COVID-19 pandemic in Alberta, CanadaErin S Mackinnon, Todd Anderson, Paulo Raggi, et al.
American Journal of Nephrology|August 14, 2003
The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patientsGlenn M Chertow, Paolo Raggi, James T McCarthy, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2020
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trialsOlivia R Ghosh-Swaby, Shaun G Goodman, Lawrence A Leiter, et al.
American Heart Journal|November 24, 2007
Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcomeAndrew T Yan, Raymond T Yan, Mary Tan, et al.
The American Journal of Cardiology|October 30, 2010
Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatientsVineet Bhan, Raymond T Yan, Lawrence A Leiter, et al.
Circulation. Cardiovascular Interventions|November 6, 2024
Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS TrialAlexander C Fanaroff, Daniel M Wojdyla, Christopher B Granger, et al.
Journal of Invertebrate Pathology|July 18, 2017
Specificity and putative mode of action of a mosquito larvicidal toxin from the bacterium Xenorhabdus innexiIl-Hwan Kim, Jerald Ensign, Do-Young Kim, et al.
The Canadian Journal of Cardiology|November 19, 2013
Characteristics and evidence-based management of stable coronary artery disease patients in Canada compared with the rest of the world: insights from the CLARIFY registrySumeet Gandhi, Paul Dorian, Nicola Greenlaw, et al.
Kidney International|April 5, 2003
Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysisIsidro B Salusky, William G Goodman, Beatriz D Kuizon, et al.
CJC Open|September 30, 2020
Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary SyndromeDavid H Fitchett, Lawrence A Leiter, Peter Lin, et al.
Pageof 112